Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management Strategies for Neutropenia and Anemia in HIV/HCV Coinfected Patients
NCT00194857Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2002
- Primary completion
- Dec 2005
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin and granulocyte colony-stimulating factor in anemia and neutropenia (2 arms), sponsored by Weill Cornell Medicine. Primary endpoints: Change in Hemoglobin and Change in Absolute Neutrophil Count. Started Feb 2002; status: terminated.
02
Drugs
erythropoietingranulocyte colony-stimulating factor
03
Conditions
anemianeutropenia
Beyond the preview
Go deeper on NCT00194857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194857.